Biblio
“The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
, “Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife.”, J Alzheimers Dis, vol. 100, no. 3, pp. 935-943, 2024.
, “BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.”, J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
, “Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases.”, J Alzheimers Dis, vol. 100, no. s1, pp. S93-S101, 2024.
, “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
, “Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1407-1419, 2024.
, “A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
, “Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
, “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
, “Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.”, J Alzheimers Dis, vol. 99, no. s2, pp. S187-S234, 2024.
, “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
, “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
, “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
, “Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.”, J Alzheimers Dis, vol. 101, no. 2, pp. 397-415, 2024.
, “Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 100, no. 3, pp. 973-986, 2024.
, “Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia.”, J Alzheimers Dis, vol. 102, no. 1, pp. 67-76, 2024.
, “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
, “Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1139-1159, 2024.
, “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
, “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
, “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
, “Current Status and Challenges in Dementia Care in the Philippines: A Scoping Review.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1533-1543, 2024.
, “Dementia Ideal Care: Ecosystem Map of Best Practices and Care Pathways Enhanced by Technology and Community.”, J Alzheimers Dis, vol. 100, no. 1, pp. 87-117, 2024.
, “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
, “Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 3, pp. 1017-1037, 2024.
,